Regulation of Opioid and Cannabinoid Receptor Genes in Human Neuroblastoma and T Cells by the Epigenetic Modifiers Trichostatin A and 5-Aza-2’-Deoxycytidine

Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase A-dependent mechanism

(2011) Barbara Rossi et al.   JOURNAL OF NEUROIMMUNOLOGY

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease

(2010) Cristina Blázquez et al.   BRAIN

Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4

(2010) Jürgen Kraus et al.   MOLECULAR IMMUNOLOGY

Up-Regulation of the  -Opioid Receptor Gene Is Mediated through Chromatin Remodeling and Transcriptional Factors in Differentiated Neuronal Cells

(2010) C. K. Hwang et al.   MOLECULAR PHARMACOLOGY

Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling

(2009) Christine Börner et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cannabinoid (CB1), GABAA and GABAB receptor subunit changes in the globus pallidus in Huntington's disease

(2009) K.L. Allen et al.   JOURNAL OF CHEMICAL NEUROANATOMY

Mechanisms of Opioid-Mediated Inhibition of Human T Cell Receptor Signaling

(2009) C. Borner et al.   JOURNAL OF IMMUNOLOGY

Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies

(2009) Rocio G Urdinguio et al.   LANCET NEUROLOGY

T-Cell Receptor/CD28-Mediated Activation of Human T Lymphocytes Induces Expression of Functional  -Opioid Receptors

(2008) C. Borner et al.   MOLECULAR PHARMACOLOGY

Novel cannabinoid receptors

(2007) A J Brown   BRITISH JOURNAL OF PHARMACOLOGY